Trial
NCT03389685
Can PRP Reduce Pro-Inflammatory Biomarkers Following ACL Injury
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
NYU Langone Health
Collaborators
—
Condition
ACL - Anterior Cruciate Ligament Rupture
Intervention
Platelet Rich Plasma
Why stopped
COVID-19, Lack of Funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-15